Pediatric transplantation: Ten years on: Editorial

Pediatric Transplantation

Volumn 13, Issue 3, 2009, Pages 272-277

  Benden, Christian ^a   Dipchand, Anne I ^b   Danziger Isakov, Lara A ^c   Esquivel, Carlos O ^d   Ringdén, Olle ^e   Wray, Jo ^f   Marks, Stephen D ^g  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PSORALEN; RITUXIMAB; TACROLIMUS; THALIDOMIDE;

BONE MARROW TRANSPLANTATION; CARDIOVASCULAR RISK; CHRONIC ALLOGRAFT NEPHROPATHY; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; EDITORIAL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; LIVER GRAFT; LUNG GRAFT REJECTION; LYMPHOPROLIFERATIVE DISEASE; METABOLIC DISORDER; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; QUALITY OF LIFE; RISK FACTOR; SICKLE CELL ANEMIA; SOCIAL PSYCHOLOGY; STEM CELL TRANSPLANTATION; THALASSEMIA; ULTRAVIOLET RADIATION; VASCULAR DISEASE;

CHILD; COMMUNICABLE DISEASES; FORECASTING; GRAFT SURVIVAL; HUMANS; ORGAN TRANSPLANTATION; PRIMARY GRAFT DYSFUNCTION; QUALITY OF LIFE;

EID: 64149115534     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01096.x     Document Type: Editorial

References (49)

1. Magee JC, Krishnan SM, Benfield MR, Hsu DT, Shneider BL. Pediatric transplantation in the United States, 1997-2006. Am J Transplant 2008 : 8 : 935 945.
2. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant recipients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987 : 76 : 827 834.
3. Colvin RB. Renal transplant pathology. In : Jennette JC, Olsen JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney, 5th edn. Philadelphia : Lippincott-Raven, 1998 : pp. 1409 1540.
4. An International Panel. Update of the international Banff schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 2000 : 31 : 792 799.
5. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003 : 22 : 1007 1028.
6. Pahl E, Naftel DC, Kuhn MA, et al. The impact and outcome of transplant coronary artery disease in a pediatric population: A 9-year multi-institutional study. J Heart Lung Transplant 2005 : 24 : 645 651.
7. Kuhn MA, Jutky KR, Deming DD, et al. The medium-term findings in coronary arteries by intravascular ultrasound in infants and children after heart transplantation. J Am Coll Cardiol 2000 : 36 : 250 254.
8. Mahle WT, Vincent RN, Berg AM, et al. Pravastatin therapy in associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. J Heart Lung Transplant 2005 : 24 : 63 66.
9. Nicholas RT, Kort HW, Balzer DT, et al. Surveillance for transplant coronary artery disease in infant, child and adolescent heart transplant recipients: An intravascular ultrasound study. J Heart Lung Transplant 2006 : 25 : 921 927.
10. Shirali GS, Ni J, Chinnock RE, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001 : 344 : 1498 1503.
11. Boucek MM, Aurora P, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Tenth official pediatric heart transplantation report - 2007. J Heart Lung Transplant 2007 : 26 : 796 807.
12. Tejani A, Sullivan EK. The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2000 : 4 : 107 111.
13. Womer KL, Vella JP, Sayegh MH. Chronic allograft dysfunction: Mechanism and new approaches to therapy. Semin Nephrol 2000 : 20 : 126 147.
14. Benfield MR, McDonald RA, Bartosh S, Ho PL, Harmon W. Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2003 : 7 : 321 335.
15. Gupta P, Hart J, Cronin D, et al. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001 : 72 : 1098 1102.
16. Weisner RH, Batts KP, Krom RAF. Evolving concepts in the diagnosis, pathogenesis and treatment of chronic hepatic allograft rejection. Liver Transpl Surg 1999 : 5 : 388 400.
17. Fridell JA, Jain A, Reyes J, et al. Causes of mortality beyond one year after primary pediatric liver transplant under tacrolimus. Transplantation 2002 : 74 : 1721 1724.
18. Aurora P, Edwards LB, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: Eleventh official pediatric lung and heart-lung transplantation report - 2008. J Heart Lung Transplant 2008 : 27 : 978 983.
19. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft vasculopathy in cardiac-transplant recipients. N Engl J Med 2003 : 349 : 847 858.
20. Kaczmarek I, Ertl B, Schmauss D, et al. Preventing cardiac allograft vasculopathy: Long-term beneficial effects of mycophenolate mofetil. J Heart Lung Transplant 2006 : 25 : 550 556.
21. Mehra MR, Ventura HO, Smart FW, et al. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: From bench to bedside. J Heart Lung Transplant 1995 : 14 : S246 S249.
22. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995 : 10 : 621 627.
23. Mancini D, Pinney S, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003 : 103 : 48 53.
24. Ringdén O, Deeg HJ. Clinical spectrum of graft-versus-host disease. In : Ferrara JLM, Deeg HJ, Burakoff S, eds. Graft vs Host Diseas, 2nd edn. New York : Marcel Dekker, Inc, 1996 : pp. 525 559.
25. Krmar RT, Balzano R, Jogestrand T, Cedazo-Minguez A, Englund MS, Berg UB. Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients. Pediatr Transplant 2008 : 12 : 412 419.
26. Dalla Pozza R, Urschel S, Bechtold S, Kozlik-Feldmann R, Schmitz C, Netz H. Subclinical atherosclerosis after heart and heart-lung transplantation in childhood. Pediatr Transplant 2008 : 12 : 577 581.
27. Allen UD. Current status and impact of CMV prevention following pediatric organ transplantation. Pediatr Transplant 2008 : 12 : 389 392.
28. Puliyanda DP, Toyoda M, Traum AZ, et al. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant 2008 : 12 : 180 186.
29. Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR. Pediatr Transplant 2008 : 12 : 464 468.
30. Green M, Soltys K, Rowe DT, Webber SA, Mazareigos G. Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients. Pediatr Transplant 2009. 13 : 319 323.
31. Nolte FS, Marshall DJ, Rasberry C, et al. MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol 2007 : 45 : 2779 2786.
32. Wada K, Kubota N, Ito Y, et al. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol 2007 : 45 : 1426 1432.
33. Steinbach WJ, Addison RM, McLaughlin L, et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007 : 26 : 558 564.
34. Lin CC, Chen CL, Concejero A, et al. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant 2007 : 7 : 195 200.
35. Radley-Smith R, Wray J, Chinnock R, Uzark K. Child development post-transplant: Growth, intellectual/developmental functioning, and psychosocial functioning. In : Canter CE, Kirklin JK, eds. Pediatric Heart Transplantation (ISHLT Monograph series 2). New York : Elsevier, 2008 : pp. 203 214.
36. Alonso EM, Neighbors K, Barton FB, et al. Health-related quality of life and family function following pediatric liver transplantation. Liver Transpl 2008 : 14 : 460 468.
37. Falger J, Landolt MA, Latal B, et al. Outcome after renal transplantation. Part II: Quality of life and psychosocial adjustment. Pediatr Nephrol 2008 : 23 : 1347 1354.
38. Lof CM, Forinder U, Winiarski J. Risk factors for lower health-related QoL after allogeneic stem cell transplantation in children. Pediatr Transplant 2007 : 1 : 145 151.
39. Simons LE, Blount RL. Identifying barriers to medication adherence in adolescent transplant recipients. J Pediatr Psychol 2007 : 32 : 831 844.
40. Svahn B-M, Remberger M, Myrbäck K-E, et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared to hospital care. Blood 2002 : 100 : 4317 4324.
41. Bartosh SM, Ryckman FC, Shaddy R, Michaels MG, Platt JL, Sweet SC. A national conference to determine research priorities in pediatric solid organ transplantation. Pediatr Transplant 2008 : 12 : 152 166.
42. Zanjani ED, Ascensao JL, Flake AW, et al. The fetus as an optimal donor and recipient of hemopoietic stem cells. Bone Marrow Transplant 1992 : 10 : 107 114.
43. Le Blanc K, Ringdén O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005 : 11 : 321 334.
44. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of severe refractory acute graft-versus-host disease. Lancet 2008 : 371 : 1579 1586.
45. Ringdén O, Uzunel M, Sundberg B, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007 : 21 : 2271 2276.
46. Kolb HJ, Mittermuller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990 : 76 : 2462 2465.
47. NAPRTCS. North American Pediatric Renal Trials and Collaborative Studies 2007 Annual Report. http://www.web.emmes.com/study/ped/annlrept/annlrept2007.pdf
48. McDiarmid SV, Anand R, Lindblad AS, Group SR. Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 2004 : 8 : 284 294.
49. Benden C, Danziger-Isakov LA, Astor T, et al. Variability in immunization guidelines in children before and after lung transplantation. Pediatr Transplant 2007 : 11 : 882 887.